Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results
Appointed director

CHAMPIONS ONCOLOGY, INC. (CSBR) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/10/2023 4 Mendelson Daniel Newman (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.
Txns: Bought 1,530 shares @ $6.48, valued at $9.9k
10/06/2023 4 Mendelson Daniel Newman (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.
Txns: Bought 2,000 shares @ $6.47, valued at $12.9k
10/04/2023 4 Mendelson Daniel Newman (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.
Txns: Bought 2,500 shares @ $6.3, valued at $15.8k
10/04/2023 4 Mendelson Daniel Newman (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.
Txns: Bought 5,000 shares @ $6.4, valued at $32k
09/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/17/2023 4 ACKERMAN JOEL (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.
Txns: Granted 26,500 options to buy @ $7, valued at $185.5k
08/17/2023 4 Breitfeld Philip P. (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.
Txns: Granted 11,480 options to buy @ $7, valued at $80.4k
08/17/2023 4 Mendelson Daniel Newman (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.
Txns: Granted 19,430 options to buy @ $7, valued at $136k
08/17/2023 4 SIDRANSKY DAVID (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.
Txns: Granted 11,480 options to buy @ $7, valued at $80.4k
08/17/2023 4 TOBIN SCOTT R (10% Owner) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.
Txns: Granted 21,200 options to buy @ $7, valued at $148.4k
07/24/2023 10-K Annual Report for the period ended April 30, 2023
07/24/2023 8-K Quarterly results
04/05/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "One University Plaza, Suite 307 Hackensack, NJ 07601 Tel: 551-206-8104 Champions Oncology Announces $5M Stock Repurchase Program"
03/21/2023 4 Morris Ronnie (CEO) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.
Txns: Bought 12,382 shares @ $4.0356, valued at $50k
03/16/2023 10-Q Quarterly Report for the period ended January 31, 2023
03/15/2023 8-K Quarterly results
Docs: "One University Plaza, Suite 307 Hackensack, NJ 07601 Tel: 551-206-8104 Champions Oncology Reports Quarterly Revenue of $12.8 Million"
12/13/2022 10-Q Quarterly Report for the period ended October 31, 2022
12/13/2022 8-K Quarterly results
10/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/20/2022 8-K Quarterly results
10/14/2022 4 SIDRANSKY DAVID (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.
Txns: Paid exercise price by delivering 3,562 shares @ $7.51, valued at $26.8k
Exercised 8,333 options to buy @ $3.21, valued at $26.7k
10/14/2022 4 Breitfeld Philip P. (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.
Txns: Paid exercise price by delivering 3,562 shares @ $7.51, valued at $26.8k
Exercised 8,333 options to buy @ $3.21, valued at $26.7k
10/13/2022 4 TOBIN SCOTT R (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.
Txns: Exercised 10,000 options @ $3.21, valued at $32.1k
09/12/2022 10-Q Quarterly Report for the period ended July 31, 2022
09/08/2022 8-K Quarterly results
Docs: "One University Plaza, Suite 307 Hackensack, NJ 07601 Tel: 551-206-8104 Champions Oncology Reports Record Quarterly Revenue of $13.7 Million"
08/31/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
08/29/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
08/29/2022 DEFC14A Form DEFC14A - Definitive proxy statement, contested solicitations:
07/22/2022 10-K Annual Report for the period ended April 30, 2022
07/21/2022 8-K Quarterly results
03/15/2022 10-Q Quarterly Report for the period ended January 31, 2022
03/15/2022 8-K Quarterly results
Docs: "One University Plaza, Suite 307 Hackensack, NJ 07601 Tel: 551-206-8104 Champions Oncology Reports Record Quarterly Revenue of $13.2 Million Reported Adjusted EBITDA of $1.5 million"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy